Slide
About Kerato
About Kerato
About Kerato

Kerato Limited is a North-East England based biotech company developing innovative bioengineered corneal tissue products for medical, commercial and research applications.

Our team includes world leading academic experts in tissue engineering with commercial operational expertise.

Kerato uses cells and collagen to produce corneas in the laboratory that are comparable to those of human donors. The Company has a dedicated commercial team and has recently appointed a Managing Director, Sarah Greenhalgh, to oversee the development of product offerings and the execution of the product and sales strategy.

Our parent company is BSF Enterprise, and, with our fellow portfolio companies including 3D Bio-Tissues, we are working to support their vision of unlocking the next generation of biotech solutions.


Our Team

Kerato’s team include world leading academic experts in tissue engineering combined with commercial and operational expertise, and a track record of international collaborations,

Sarah Greenhalgh
Sarah Greenhalgh
Co-Founder & Managing Director

Sarah has more than 20 years experience managing technically innovative projects & clinical trials within SMEs/Start-ups and Academic Research.

Dr Che Connon
Dr Che Connon
Co-Founder & Director
Che has over 20 years of experience in extracellular matrix biology and is currently a Professor of Tissue Engineering.
Dr Ricardo Gouveia
Dr Ricardo Gouveia
3DBT Chief Scientific Officer
Ricardo is a scientist with expertise in Biochemistry, Biotechnology and Bioengineering. With almost 20 years of research experience in stem cell biology and tissue biofabrication.
Dr Miguel Jarrin
Dr Miguel Jarrin
3DBT Chief Technical Officer
Miguel is a cell biologist with a long career in the eye field. Miguel spent more than twenty years studying the different signalling pathways.
Enrico Torre
Enrico Torre
Research Student
Enrico is a 3rd year PhD student at Newcastle University funded by 3DBT.

Investment Partner

BSF Enterprise is building a portfolio of pioneering clinical and cellular agriculture companies, including 3D Bio-Tissues, Kerato, and Lab Grown Leather, with the ambition of unlocking the next generation of biotech solutions.

This goal is being achieved through an acquisition-led growth strategy to drive the development of lab-grown tissues. Cell-based tissue engineering can generate cultured meat, lab-grown leather, human corneas, collagen growth and skin substitutes.

These technologies will contribute to a radical transformation of the delivery of sustainable solutions across a variety of sectors.

Scientific Partner

3D Bio-Tissues (3DBT) is at the forefront of producing bio-equivalent tissues for clinical and cellular agriculture applications, utilising novel bio-inspired manufacturing processes to generate complex structures.

3DBT are Kerato's ongoing R&D collaborator, and their their expertise in biosynthetic corneal tissue continues to support expansion of Kerato's portfolio of products and services.


Helping Reduce 13m Patient Waiting
for Cornea Transplants
in hospitals

Helping Reduce Animal Testing

Want to learn more about what we do, and how we could work with your business or research group? Get in touch!
Investment Partner
Scientific Partner
© Kerato Limited  2024. All Rights Reserved 
crossmenuchevron-down